N.XT Portfolio
Startup Metrics*
111 Employees | 42 Products | $85.5M Funds Raised
*In aggregate across startups
Current Investments
| TECHNOLOGY / COMPANY | DETAILS |
PreDx
|
Investment Stage: Company Funding Year: 2023 Faculty: Thomas Meade Real-time, noninvasive monitoring of gene therapy biodistribution using bio-responsive MRI contrast agents. |
MFNS Tech
|
Investment Stage: Company Funding Year: 2023 Faculty: Vinayak Dravid Nanostructure coating for economic, efficient, and eco-friendly removal of oil and other contaminants from water. |
CosmeTec
|
Investment Stage: Company Funding Year: 2022 Faculty: Nathan Gianneschi A cleaner, safer, PPD-free hair dye based on synthetic melanin. |
Syenex
|
Investment Stage: Company Funding Year: 2022 Faculty: Josh Leonard Breakthrough gene delivery technologies combining synthetic biology, engineering, and extracellular vesicles. |
Opera Bioscience |
Investment Stage: Company Funding Year: 2022 Faculty: Danielle Tullman-Ercek Cost-effective, microbial protein production platform that secretes high-purity, soluble, correctly folded recombinant proteins out of the cell in a single step. |
Voice Savvy |
Investment Stage: Technology Funding Year: 2021 Faculty: Theresa Brancaccio & John Rogers A mobile app for calculating vocal load and helping busy voice users monitor their vocal health. |
History Adventures |
Investment Stage: Technology Funding Year: 2021 Faculty: Spencer Striker An interactive digital platform that brings engaging history lessons to middle and high school students. In 2024, the startup History Adventures was spun out of this technology. |
Cities Learn
|
Investment Stage: Technology Funding Year: 2021 Faculty: Nichole Pinkard A unified data system that tracks youth participation, achievement, and activity outside the classroom and aims to democratize access to afterschool activities. |
TunePad (now Eccentric Orbit) |
Investment Stage: Technology Funding Year: 2021 Faculty: Michael Horn Online platform for creating music through the Python programming language with the goal of broadening participation in computing. In 2022, the startup Eccentric Orbit was spun out of this technology. |
Stemloop
|
Investment Stage: Company Funding Year: 2020 Faculty: Julius Lucks & Michael Jewett (former NU faculty) Cell-free biosensors that enable rapid, low-cost solutions for the on-site detection of pathogens and chemical contaminants. |
Azul 3D |
Investment Stage: Company Funding Year: 2019 Faculty: Chad Mirkin High-throughput 3D printing technologies that enable printing of large objects at unparalleled speeds from a wide range of consumer and industrial grade plastics. |
Rhaeos |
Investment Stage: Company Funding Year: 2019 Faculty: John Rogers Noninvasive, wireless, wearable thermal sensor for assessing the flow of cerebrospinal fluid in hydrocephalus patients and monitoring ventricular shunt function. |
Yobee Care |
Investment Stage: Company Funding Year: 2018 Faculty: Ruchi Gupta All-natural scalp treatment for reducing inflammation and restoring the balance of the scalp and skin microbiome. |
Preora Healthcare (spinout: ASP Health)
|
Investment Stage: Company Funding Year: 2017 Faculty: Vadim Backman Platform that measures nanoscale cellular changes for the early detection and treatment of cancer. In 2020, ASP Health was spun out of Preora Healthcare to commercialize an innovative sample preparation technology for enhanced cancer diagnosis. |
Battery Technology (now Volexion)
|
Investment Stage: Technology Funding Year: 2017 Faculty: Mark Hersam Advanced graphene coating technology for lithium-ion cathode materials that boosts battery performance by 10x. In 2018, Volexion was spun out from this technology. |
ALS Therapy (now AKAVA Therapeutics)
|
Investment Stage: Technology Funding Year: 2016 Faculty: Richard Silverman & Hande Ozdinler First-in-class small molecule therapeutics that inhibit protein aggregation and improve the health of upper motor neurons in ALS other neurodegenerative diseases. In 2019, AKAVA Therapeutics was spun out from this technology. |
